Stock Track | DIAGENS-B Soars 113.94% on Trading Debut as Medical Imaging AI Firm Opens at Significant Premium to IPO Price

Stock Track03-30

DIAGENS-B's stock soared 113.94% intraday on Monday as the biotechnology company made its trading debut on the Hong Kong Stock Exchange.

The company's initial public offering was priced at HK$99 per share, but shares opened at HK$219 each, representing a substantial premium to the offer price. DIAGENS-B raised HK$719.8 million in net proceeds from its IPO, with the Hong Kong public offer being 1,073.37 times subscribed, indicating strong investor demand.

The company operates in the medical imaging artificial intelligence sector, having launched the iMedImage® general-purpose medical imaging large model. According to its prospectus, the company reported revenue growth of 469.8% year-on-year for the first nine months of 2025, with a gross profit margin of 75.9%, contributing to investor enthusiasm for the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1162103240?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-30 09:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162103240","market":"nz","top_or_hot":-1,"title":"Stock Track | DIAGENS-B Soars 113.94% on Trading Debut as Medical Imaging AI Firm Opens at Significant Premium to IPO Price","media":"Stock Track","content":"<p>DIAGENS-B's stock soared 113.94% intraday on Monday as the biotechnology company made its trading debut on the Hong Kong Stock Exchange.</p><p>The company's initial public offering was priced at HK$99 per share, but shares opened at HK$219 each, representing a substantial premium to the offer price. DIAGENS-B raised HK$719.8 million in net proceeds from its IPO, with the Hong Kong public offer being 1,073.37 times subscribed, indicating strong investor demand.</p><p>The company operates in the medical imaging artificial intelligence sector, having launched the iMedImage® general-purpose medical imaging large model. According to its prospectus, the company reported revenue growth of 469.8% year-on-year for the first nine months of 2025, with a gross profit margin of 75.9%, contributing to investor enthusiasm for the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | DIAGENS-B Soars 113.94% on Trading Debut as Medical Imaging AI Firm Opens at Significant Premium to IPO Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | DIAGENS-B Soars 113.94% on Trading Debut as Medical Imaging AI Firm Opens at Significant Premium to IPO Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-30 09:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DIAGENS-B's stock soared 113.94% intraday on Monday as the biotechnology company made its trading debut on the Hong Kong Stock Exchange.</p><p>The company's initial public offering was priced at HK$99 per share, but shares opened at HK$219 each, representing a substantial premium to the offer price. DIAGENS-B raised HK$719.8 million in net proceeds from its IPO, with the Hong Kong public offer being 1,073.37 times subscribed, indicating strong investor demand.</p><p>The company operates in the medical imaging artificial intelligence sector, having launched the iMedImage® general-purpose medical imaging large model. According to its prospectus, the company reported revenue growth of 469.8% year-on-year for the first nine months of 2025, with a gross profit margin of 75.9%, contributing to investor enthusiasm for the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02526","symbol_name":"德适-B","start_time":0,"source_url":"","article_id":"1162103240","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162103240","pubTimestamp":1774834756,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"DIAGENS-B's stock soared 113.94% intraday on Monday as the biotechnology company made its trading debut on the Hong Kong Stock Exchange.The company's initial public offering was priced at HK$99 per...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02526":"德适-B"},"translate_title":"个股追踪|DIAGENS-B首次交易飙升113.94%，医疗影像AI公司开盘较IPO价格大幅溢价","themeId":"eabc27e292d5d2a1d0e6ab47c9d0d348","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02526":1},"content_text":"DIAGENS-B's stock soared 113.94% intraday on Monday as the biotechnology company made its trading debut on the Hong Kong Stock Exchange.The company's initial public offering was priced at HK$99 per share, but shares opened at HK$219 each, representing a substantial premium to the offer price. DIAGENS-B raised HK$719.8 million in net proceeds from its IPO, with the Hong Kong public offer being 1,073.37 times subscribed, indicating strong investor demand.The company operates in the medical imaging artificial intelligence sector, having launched the iMedImage® general-purpose medical imaging large model. According to its prospectus, the company reported revenue growth of 469.8% year-on-year for the first nine months of 2025, with a gross profit margin of 75.9%, contributing to investor enthusiasm for the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1162103240","isCrawlerRequest":true}